Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Basic and Clinical Toxicology of Mustard Compounds (eBook)

eBook Download: PDF
2015 | 1st ed. 2015
XV, 408 Seiten
Springer International Publishing (Verlag)
978-3-319-23874-6 (ISBN)

Lese- und Medienproben

Basic and Clinical Toxicology of Mustard Compounds -
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

This book offers a practical guide to the clinical management of sulphur and nitrogen mustard exposure including information on the history, pharmacology and toxicology of mustard compounds (MC).

Basic and Clinical Toxicology of Mustard Compounds details the many resulting complications of sulphur mustard (SM) poisoning such as respiratory, Dermatological, Ophthalmological and Psychiatric.

This volume is a key resource for clinical toxicologists, military and emergency physicians who are involved in the teaching and research of MC and for all medical and health professions who are responsible for the prevention, diagnosis and treatment of MC poisonings.



Mahdi Balali-Mood was awarded B.Sc. 1st class Hon of chemistry in 1963 and then MD in 1970 from Tehran University. After his medical military service and training in internal medicine/clinical toxicology, he was appointed as an assistant professor in clinical toxicology and head of his newly established Poisoning Treatment Center (PTC) of Mashhad University in 1974. Mahdi was awarded a scholarship from the Ministry of Science of Iran and did his

PhD in Clinical Pharmacology & Toxicology at Edinburgh University Medical School in 1978-1981. He was then working as a lecturer in this department until winter 1982, when decided to return to Mashhad to advance his established PTC, as the chemical war gas attack of Iraqi army against Iranian troops was his main concern.

 

Mahdi promoted to Associate Professor and full professor of Medicine and Clinical Toxicology, Mashhad University Medical Sciences (MUMS) in 1984 and 1988, respectively.

He has served as a Clinical Toxicology Adviser to the International Programme on Chemical Safety (IPCS) and the World Health Organization (WHO) 1989 to date. He has also been a member of the IPCS Programme Advisory Committee since 2000.

 

Prof. Balali-Mood was a founding member and the first President of Iranian Society of Toxicology and was also elected twice as the president of Irantox between 1989 and 2

001. He has been a

member of the Iranian Academy of Medical Sciences since its establishment in 1990.

 

Mahdi with collaboration of the other Internationally recognized medical toxicologists founded the Asia-Pacific Association of Medical Toxicology (1989) and served as the first Vice-President and then as the President for 8 years (1994-2001). He was elected as a Permanent Member of the Academy of Sciences for Developing World (TWAS) in 1997. He was a member of Scientific Advisory Board of the Organization for Prohibition of Chemical Weapons (OPCW) 2004 to 2011.

 

His other achievements include co-founder and Director, Medical Toxicology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, 1988 to date,  Ed

itor-in-Chief, Scientific Journal of Birjand University of Medical Sciences 2002 to date, Associate Editor and editorial board member of many national and International medical journals.

His research areas are Clinical Toxicology of Chemical Warfare Agents, Organophosphorous Pesticide Poisonings. Heavy Metals, Drug Abuse/Overdosage, Epidemiology of Poisonings, Occupatioal and Environmental Toxicology, Natural Toxins including snake and spider bites.

 

Prof. Balali-Mood was awarded several National and International prizes on Teaching, Research and Medical Care including the prizes in medical c

100 theses for MSc, PhD, PharmD, MD and specialities in clinical medicine, mostly on CWA. Mahdi is the author/editor of 29 books/monographs/chapters and 147 articles and 289 short papers and abstracts. His recent books on Basic and Clinical Toxicology of organophosphorus compounds and on Biological Toxins and Bioterrorism were published by Springer in 2014 and 2015, respectively.




Mohammad Abdollahi (MA) acquired a PharmD in 1988 from the University of Tehran and then finished a PhD in Toxicology and Pharmacology in 1994 from the Tehran University of Medical Sciences. in 2001, MA completed his postdoctoral training in Mechanistic Toxicology in the school of Pharmacy of the University of Toronto. In the interim, he contributed in a key Meta-analysis study in the School of Medicine, University of Toronto. MA has obtained the honor of full professorship of Tehran University of Medical Sciences (TUMS) since the second half of 2002. He has chaired the Department of Toxicology

and Pharmacology at the Faculty of Pharmacy, TUMS since 2005.  So far, MA has contributed in authoring more than 600 papers in prestigious journals and authoring 48 book chapters and editing 11 books. MA has been listed among top scientists of ESI/ISI and OIC Member States. According to Google Scholar, current H-index, total citations, and i10 index of MA are 64, ≅15000, and 330, respectively. Total citations of MA in the books are more than 1000. MA is the Editor-in-Chief of two TUMS prestigious journals published by Springer BMC and Elsevier. MA has cooperated with some key international organizations such as OPCW (Organization for Prohibition of Chemical Weapons) as a Scientific Advisory Board in the Netherlands (since 2012), WHO (World Health Organization) as a Member of Guideline Developing Group for Prevention of Lead Poisoning in Switzerland (since 2011), COPE (Committee on Publication Ethics) as a Council Member in the UK (2013-2014), World Library of Toxicology as the Country Correspondent (since 2008), IAS (Islamic-World Academy of Sciences) as a Fellow (since 2007), International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Iran Chapter as a Founder/Board of Directors (since 2013), and Asian Council of Science Editors as the Board of Directors (since 2014). In addition to more than ten prestigious national awards, MA has received the prominent award of IAS-COMSTECH in 2005 in the field of Pharmacology & Toxicology. The main research interests of MA are Mechanistic and Environmental Toxicology, Evidence-Based Medicine, and Pharmacology. MA's contribution to this field is attested by an extensive array of citations in papers and books. MA has uncovered the critical mechanistic connections between the toxicity of chemicals and the etiology of human diseases.


 


 




Mahdi Balali-Mood attended Tehran University, where he was awarded a B.Sc. First-Class Honor in Chemistry in 1963 and then an M.D. in 1970. After his medical military service and training in internal medicine and clinical toxicology, he was appointed an assistant professor in clinical toxicology and became the head of his newly established Poisoning Treatment Center (PTC) at Mashhad University in 1974. He was awarded a scholarship from the Ministry of Science of Iran and completed his Ph.D. in clinical pharmacology and toxicology at Edinburgh University Medical School (1978–1981). He continued at the school as a lecturer until 1982, when he decided to return to Mashhad to advance his established PTC.Dr. Balali-Mood was promoted to associate professor and then full professor of medicine and clinical toxicology at the Mashhad University of Medical Sciences (MUMS) in 1984 and 1988, respectively. He has served as a clinical toxicology adviser to the International Programme on Chemical Safety (IPCS) and the World Health Organization from 1989 to the present. He has also been a member of the IPCS Programme Advisory Committee since 2000.Dr. Balali-Mood was a founding member and the first president of the Iranian Society of Toxicology and was twice elected president of Irantox between 1989 and 2001. He has been amember of the Iranian Academy of Medical Sciences since its establishment in 1990. In collaboration with a group of internationally recognized medical toxicologists, he founded the Asia-Pacific Association of Medical Toxicology (in 1989) and served as the organization’s first vice president and then as its president for 8 years (1994–2001). He was elected as a permanent member of the Academy of Sciences for the Developing World in 1997. He was also a member of the Scientific Advisory Board of the Organization for the Prohibition of Chemical Weapons from 2004 to 2011. Additionally, he is the co-founder of the Medical Toxicology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, where he has served as director since 1988. He is also Editor-in-Chief of the Scientific Journal of Birjand University of Medical Sciences (since 2002) and an associate editor or editorial board member of numerous national and international medical journals. Dr. Balali-Mood’s research areas include clinical toxicology of chemical warfare agents, organophosphorous pesticide poisonings, heavy metals, drug abuse and overdosage, epidemiology of poisonings, occupational and environmental toxicology, and natural toxins, including snake and spider venoms. He is the author or editor of 29 books and book chapters, 147 articles, and 289 short papers and abstracts. He is also the recipient of several national and international prizes for teaching, research, and medical care. His recent books Basic and Clinical Toxicology of Organophosphorus Compounds (also with Mohammad Abdollahi) and Biological Toxins and Bioterrorism were published by Springer in 2014 and 2015, respectively.  Mohammad Abdollahi earned a Pharm.D. in 1988 from the University of Tehran and later completed a Ph.D. in toxicology and pharmacology in 1994 at the Tehran University of Medical Sciences. In 2001, Dr. Abdollahi completed his postdoctoral training in mechanistic toxicology at the University of Toronto’s School of Pharmacy. While in Toronto, he also contributed to a key meta-analysis study at the university’s School of Medicine. In 2002 he was given a full professorship at the Tehran University of Medical Sciences. There he has chaired the Department of Toxicology and Pharmacology in the Faculty of Pharmacy since 2005. Dr. Abdollahi has authored or coauthored more than 600 journal articles and 48 book chapters and has edited 11 books. He is the Editor-in-Chief of DARU Journal of Pharmaceutical Sciences and the Journal of Medical Hypotheses and Ideas. Additionally, he has served on the Scientific Advisory Board of the Organization for the Prohibition of Chemical Weapons (since 2012); as a member of the World Health Organization’s Guidelines Development Group for the Prevention of Lead Poisoning (since 2011); as a council member of the Committee on Publication Ethics (2013–2014); as Iran’s country correspondent to the World Library of Toxicology (since 2008); as a fellow of the Islamic-World Academy of Sciences (since 2007); on the Board of Directors of the Iran Chapter of the International Society of Pharmacoeconomics and Outcomes Research (since 2013), of which is also a founding member; and on the Board of Directors of the Asian Council of Science Editors (since 2014). Dr. Abdollahi is the recipient of numerous awards, including the prestigious award of IAS-COMSTECH in the field of pharmacology and toxicology (2005). His main research interests are mechanistic and environmental toxicology, evidence-based medicine, and pharmacology

Chemistry of Mustard Compounds.- History of use and epidemiology of mustard compounds.- Basic pharmacology and toxicology.- Clinical pharmacology and toxicology of mustard compounds.- Delayed complications and long term effects of SM poisonings – Experience of Iraq-Iran war.- Upper respiratory complications of SM poisoning.- Lower respiratory complications of SM poisoning.- Dermatologic aspects of sulfur mustard exposure.- Ocular injury by mustard gas; early and late complications.- Immunological and hematological complications of sulfur mustard poisoning.- Psychiatric complications of sulfur mustard (SM) poisoning.- Genotoxicity, teratogenicity and mutagenicity of SM poisoning.- Verification of SM exposure in biological samples.- Occupational and environmental mustard exposure, prevention and chemical weapons convention.- Summary and conclusion

Erscheint lt. Verlag 1.12.2015
Zusatzinfo XV, 408 p. 73 illus., 50 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Pharmazie
Schlagworte antineoplastic agent • chemical warfare agents • Chemotherapy • nitrogen mustard • sulphur mustard • toxic effects
ISBN-10 3-319-23874-4 / 3319238744
ISBN-13 978-3-319-23874-6 / 9783319238746
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 6,9 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Grundlagen und Fallbeispiele für das Medikationsmanagement

von Ina Richling; Ina Richling

eBook Download (2023)
Deutscher Apotheker Verlag
CHF 46,90